Protective effect of Dapagliflozin against Amphotericin B-induced nephrotoxicity in an experimental rat model
DOI:
https://doi.org/10.37609/srinmed.56Anahtar Kelimeler:
Dapagliflozin- Amphotericin B- nephrotoxicity- oxidative stress- SGLT‑2 inhibitor- acute kidney injuryÖz
Objective: Background: Amphotericin B deoxycholate (AmBD), a potent antifungal agent, is limited by significant nephrotoxicity. SGLT-2 inhibitors, such as dapagliflozin, exhibit renoprotective effects beyond glycemic control. This study aimed to investigate the potential protective effects of dapagliflozin against AmBD-induced nephrotoxicity in an experimental rat model.
Materials and Methods: Thirty-two Wistar albino rats were randomized into four groups (n=8): Control, AmBD (single 50 mg/kg i.p. dose), Dapagliflozin (10 mg/kg/day, gavage), and AmBD + Dapagliflozin. After seven days, serum levels of creatinine, BUN, oxidative stress markers (TOS, MDA, MPO), antioxidant enzymes (CAT, SOD, GPx), and apoptotic mediators (Bax, Bcl-2, Caspase-3) were analyzed. Renal tissues were evaluated for histopathological changes.
Results: AmBD administration induced significant acute kidney injury, characterized by elevated serum BUN and creatinine levels and severe histopathological damage, including tubular necrosis and dilatation. Co‑administration of dapagliflozin significantly attenuated these functional and structural injuries, but its effect on systemic oxidative stress and apoptotic markers could not be demonstrated in this model.
Conclusion: Dapagliflozin partially prevented AmBD-induced elevations in BUN and creatinine and significantly ameliorated histopathological damage. However, no significant effect was observed on systemic oxidative stress or apoptotic markers in this model
Referanslar
Carmo A, Rocha M, Pereirinha P, Tome R, Costa E. Antifungals: From Pharmacokinetics to Clinical Practice. Antibiotics (Basel). 2023;12(5). DOI: https://doi.org/10.3390/antibiotics12050884
Feldman L, Efrati S, Dishy V, Katchko L, Berman S, Averbukh M, et al. N-acetylcysteine ameliorates amphotericin-induced nephropathy in rats. Nephron Physiol. 2005;99(1):p23-7. DOI: https://doi.org/10.1159/000081799
Altuntas A, Yilmaz HR, Altuntas A, Uz E, Demir M, Gokcimen A, et al. Caffeic acid phenethyl ester protects against amphotericin B induced nephrotoxicity in rat model. Biomed Res Int. 2014;2014:702981. DOI: https://doi.org/10.1155/2014/702981
Varlam DE, Siddiq MM, Parton LA, Russmann H. Apoptosis contributes to amphotericin B-induced nephrotoxicity. Antimicrob Agents Chemother. 2001;45(3):679-85. DOI: https://doi.org/10.1128/AAC.45.3.679-685.2001
Odabasi Z, Karaalp A, Cermik H, Mohr J, Tigen ET, Koc M, et al. Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine. Antimicrob Agents Chemother. 2009;53(7):3100-2. DOI: https://doi.org/10.1128/AAC.00001-09
Bailey CJ, Day C, Bellary S. Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease. Curr Diab Rep. 2022;22(1):39-52. DOI: https://doi.org/10.1007/s11892-021-01442-z
Xing YJ, Liu BH, Wan SJ, Cheng Y, Zhou SM, Sun Y, et al. A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro. Front Pharmacol. 2021;12:708177. DOI: https://doi.org/10.3389/fphar.2021.708177
Drake T, Landsteiner A, Langsetmo L, MacDonald R, Anthony M, Kalinowski C, et al. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2024;177(5):618-32. DOI: https://doi.org/10.7326/M23-1490
American Diabetes A. Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes. 2022;40(1):10-38. DOI: https://doi.org/10.2337/cd22-as01
Deger M, Kaya B, Akdogan N, Kaplan HM, Bagir E, Izol V, et al. Protective effect of dapagliflozin against cyclosporine A-induced nephrotoxicity. Drug Chem Toxicol. 2022;45(6):2637-43. DOI: https://doi.org/10.1080/01480545.2021.1979996
Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-46. DOI: https://doi.org/10.1056/NEJMoa2024816
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-306. DOI: https://doi.org/10.1056/NEJMoa1811744
Chang YK, Choi H, Jeong JY, Na KR, Lee KW, Lim BJ, et al. Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury. PLoS One. 2016;11(7):e0158810. DOI: https://doi.org/10.1371/journal.pone.0158810
Shibusawa R, Yamada E, Okada S, Nakajima Y, Bastie CC, Maeshima A, et al. Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death. Sci Rep. 2019;9(1):9887. DOI: https://doi.org/10.1038/s41598-019-46402-6
Shihab EM, Kadhim HM, Shahooth SS. Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice. J Med Life. 2024;17(2):157-63. DOI: https://doi.org/10.25122/jml-2023-0343
Guide for the Care and Use of Laboratory Animals. The National Academies Collection: Reports funded by National Institutes of Health. 8th ed. Washington (DC)2011.
Aigner M, Lass-Florl C. Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached? J Fungi (Basel). 2020;6(2). DOI: https://doi.org/10.3390/jof6020066
Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol. 1979;135(3):372-6. DOI: https://doi.org/10.1016/0002-9378(79)90708-7
Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6. DOI: https://doi.org/10.1016/S0076-6879(84)05016-3
Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971;8(9):871-4. DOI: https://doi.org/10.1016/0019-2791(71)90454-X
Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469-74. DOI: https://doi.org/10.1111/j.1432-1033.1974.tb03714.x
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-69.
Mozaffari Godarzi S, Valizade Gorji A, Gholizadeh B, Mard SA, Mansouri E. Antioxidant effect of p-coumaric acid on interleukin 1-beta and tumor necrosis factor-alpha in rats with renal ischemic reperfusion. Nefrologia (Engl Ed). 2020;40(3):311-9. DOI: https://doi.org/10.1016/j.nefro.2019.10.003
Abdelrahman AM, Al Suleimani Y, Shalaby A, Ashique M, Manoj P, Nemmar A, et al. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(1):45-53. DOI: https://doi.org/10.1007/s00210-018-1564-7
Oe Y, Kim YC, Sidorenko VS, Zhang H, Kanoo S, Lopez N, et al. SGLT2 inhibitor dapagliflozin protects the kidney in a murine model of Balkan nephropathy. Am J Physiol Renal Physiol. 2024;326(2):F227-F40. DOI: https://doi.org/10.1152/ajprenal.00228.2023
Alenazi SA, Elmorsy E, Al-Ghafari A, El-Husseini A. Effect of amphotericin B-deoxycholate (Fungizone) on the mitochondria of Wistar rats’ renal proximal tubules cells. J Appl Toxicol. 2021;41(10):1620-33. DOI: https://doi.org/10.1002/jat.4151
Zhra M, Qasem RJ, Aldossari F, Saleem R, Aljada A. A Comprehensive Exploration of Caspase Detection Methods: From Classical Approaches to Cutting-Edge Innovations. Int J Mol Sci. 2024;25(10). DOI: https://doi.org/10.3390/ijms25105460
İndir
Yayınlanmış
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2025 Scientific Reports in Medicine
Bu çalışma Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License ile lisanslanmıştır.
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allows users to copy, distribute and transmit unmodified article, and make noncommercial use of the article. The CC BY license permits non-commercial re-use of an open access article, as long as the author is properly attributed.
